Significance of arginase and ornithine in malignant tumors of the human skin.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Laboratory and Clinical Medicine

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1067/MLC.2001.114543PMID 11329531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods of Enzymatic Analysis

  2019cited by this paper
• Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.

  2000cited by this paper
• Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.

  2000cited by this paper
• Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.

  2000cited by this paper
• Malignant melanoma in association with palmoplantar keratoderma

  1999cited by this paper
• Role of polyamines in mediating malignant transformation and oncogene expression.

  1999cited by this paper
• Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.

  1999cited by this paper
• Arginase and ornithine, as markers in human non-small cell lung carcinoma.

  1999cited by this paper
• Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters.

  1999cited by this paper
• Epidemiology of nonmelanoma skin cancer.

  1997cited by this paper
• Immunohistochemical study of arginase in cancer of the stomach

  1996cited by this paper
• Pretherapeutic erythrocyte polyamine spermine levels discriminate high risk relapsing patients with M1 prostate carcinoma

  1996cited by this paper
• Role of ornithine decarboxylase in epidermal tumorigenesis.

  1995cited by this paper
• Involvement of the polyamine pathway in breast cancer progression.

  1995cited by this paper
• Ornithine decarboxylase as a marker for premalignancy in the stomach.

  1995cited by this paper
• Serum arginase level in patients with gastric cancer.

  1994cited by this paper
• Effect of arginase on splenic killer cell activity in patients with gastric cancer

  1994cited by this paper
• Polyamines and prostatic carcinoma: clinical and therapeutic implications.

  1993cited by this paper
• Can arginase be a marker of the large bowel neoplasia?

  1993cited by this paper
• Clinical significance of arginase in colorectal cancer

  1992cited by this paper
• Arginase, a new marker of mammary carcinoma.

  1992cited by this paper
• Inhibition of lymphocyte proliferation by liver arginase.

  1992cited by this paper
• Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas.

  1991cited by this paper
• Grabb and Smith's Plastic Surgery

  1991cited by this paper
• Content of glucocorticoid receptor and arginase in gastric cancer and normal gastric mucosal tissues

  1989cited by this paper
• The effects of arginase on neoplasm. I. The role of arginase in the immunosuppressive effects of extract from gastric cancer.

  1987cited by this paper
• Recent advances in the biochemistry of polyamines in eukaryotes.

  1986cited by this paper
• Arginase activity during pregnancy and lactation.

  1984cited by this paper
• Arginase activity and polyamine biosynthesis in psoriasis.

  1983cited by this paper
• Purification and biochemical characterization of human liver-derived inhibitory protein (LIP).

  1983cited by this paper
• Polyamine metabolism and function.

  1982cited by this paper
• Polyamines in mammalian tumors. Part II.

  1982cited by this paper
• Immunologic Responsiveness of Patients with Cancer: Relationship to Tumor Type, Stage and Prognosis

  1981cited by this paper
• Polyamines in mammalian tumors. Part I.

  1981cited by this paper
• Characterization of arginase activity from mouse epidermis and its relation to ornithine decarboxylase induction by the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate.

  1981cited by this paper
• Role of polyamines in the control of cell proliferation and differentiation.

  1981cited by this paper
• Arginase activity and other cellular events associated with epidermal hyperplasia

  1978cited by this paper
• Purification and properties of arginase from human liver and erythrocytes.

  1978cited by this paper
• Activated macrophages kill tumour cells by releasing arginase

  1978cited by this paper
• Rapid method for determination of arginase activity in tissue homogenates.

  1971cited by this paper
• Clinical biochemistry of domestic animals

  1963cited by this paper
• Photometric estimation of proline and ornithine.

  1952cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Salivary metabolomics in oral cancer: A systematic review

  2024cites this paper
• In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators

  2023cites this paper
• Arginase-1 promotes lens epithelial-to-mesenchymal transition in different models of anterior subcapsular cataract

  2023cites this paper
• A novel combination therapy of arginine deiminase and an arginase inhibitor targeting arginine metabolism in the tumor and immune microenvironment.

  2023cites this paper
• Effects of polyamine synthesis enzymes on angiogenesis and apoptosis during endometriosis

  2022cites this paper
• Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy

  2021cites this paper
• Fusobacterium nucleatum - Friend or foe?

  2021cites this paper
• Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma

  2021cites this paper
• Enhanced Access to the Health-Related Skin Metabolome by Fast, Reproducible and Non-Invasive WET PREP Sampling

  2021cites this paper
• The role of the metabolite cargo of extracellular vesicles in tumor progression

  2021cites this paper
• Arginase‐II promotes melanoma migration and adhesion through enhancing hydrogen peroxide production and STAT3 signaling

  2020cites this paper
• Myeloid Cell-Derived Arginase in Cancer Immune Response

  2020cites this paper
• Noninvasive Epidermal Metabolite Profiling.

  2020cites this paper
• Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma

  2019cites this paper
• Arginase‐1 is neither constitutively expressed in nor required for myeloid‐derived suppressor cell‐mediated inhibition of T‐cell proliferation

  2018cites this paper
• Carcinogenesis mechanisms of Fusobacterium nucleatum.

  2017cites this paper
• Oral Vitamin D Rapidly Attenuates Inflammation from Sunburn: An Interventional Study.

  2017cites this paper
• The Relationship of Agmatine Deficiency with the Lung Cancer

  2016cites this paper
• Expression of arginase I and inducible nitric oxide synthase in the peripheral blood and lymph nodes of HIV-positive patients

  2015cites this paper
• Arginina y cáncer: implicaciones en la regulación de la respuesta antitumoral

  2014cites this paper
• Clinicopathological and prognostic implications of arginase expression in hepatocellular carcinoma.

  2013cites this paper
• Conjugated linoleic acid isomers modulate protein expression profile in rat hepatocytes

  2012cites this paper
• Patched Knockout Mouse Models of Basal Cell Carcinoma

  2012cites this paper
• Th e evaluation of plasma arginine , arginase , and nitric oxide levels in patients with esophageal cancer

  2012cites this paper
• Interação da proteina e2 do vírus da hepatite c com o receptor de ldl e cd81 presentes em células endoteliais e ativação da resposta inflamatória

  2012cites this paper
• ACTIVIDAD DE ARGINASA COMO UN MARCADOR DE CANCER DE MAMA EN PACIENTES MEXICANOS

  2012cites this paper
• Trend analysis of metabonomics and systematic review of metabonomics-derived cancer marker metabolites

  2011cites this paper
• Arginine metabolism in soft tissue sarcoma.

  2011cites this paper
• Arginase and Ornithine in Human Benign and Malignant Skin Tumors

  2010cites this paper
• Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells

  2009cites this paper
• THE EFFECT OF MICROCRYSTALLINE CHITOSAN ON THE ACTIVITY OF PYRUVATE KINASE M2 ISOENZYME INVOLVED IN REGULATING PROLIFERATION OF EHRLICH ASCITES TUMOR (EAT) CELLS IN VITRO

  2009cites this paper
• The significance of arginase I administration on the survival of mice bearing NS-1 myeloma cells.

  2009cites this paper
• L-arginine as a factor increasing arginase significance in diagnosis of primary and metastatic colorectal cancer.

  2009cites this paper
• Arginase activity in carcinoma of the gallbladder: a pilot study

  2009cites this paper
• Hepatitis C virus targets over‐expression of arginase I in hepatocarcinogenesis

  2009cites this paper
• Perioperative arginine metabolism in cancer : interorgan studies in mice

  2008cites this paper
• Enzymes of creatine biosynthesis, arginine and methionine metabolism in normal and malignant cells

  2008cites this paper
• Arginase and arginine in diagnostics of patients with colorectal cancer and patients with colorectal cancer liver metastases

  2008cites this paper
• Changes in arginase isoenzymes pattern in human hepatocellular carcinoma.

  2008cites this paper
• [New insights into arginase. Part II. Role in physiology and pathology].

  2008cites this paper
• ACTIVIDAD DE LA ARGINASA SÉRICA EN PACIENTES CON CARCINOMA GÁSTRICO.

  2006cites this paper
• Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.

  2006cites this paper
• Erythrocyte Arginase Activity in Lung Cancer Patients

  2005cites this paper
• Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency?

  2005cites this paper
• Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species1

  2004cites this paper
• Intestinal tumor and agmatine (decarboxylated arginine)

  2004cites this paper
• Arginine revisited: Minireview article

  2004cites this paper
• Human agmatinase is diminished in the clear cell type of renal cell carcinoma

  2004cites this paper
• Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice.

  2004cites this paper
• Pros and cons of L-arginine supplementation in disease

  2004cites this paper
• Effects of L-Ornithine on Metabolic Processes of the Urea Cycle in Human Keratinocytes

  2004cites this paper
• Pharmacological characteristics of the specific transporter for the endogenous cell growth inhibitor agmatine in six tumor cell lines

  2003cites this paper